Remedent Company Top Insiders
| REMI Stock | USD 0.0006 0.0001 20.00% |
Remedent employs about 3 people. The company is managed by 5 executives with a total tenure of roughly 30 years, averaging almost 6.0 years of service per executive, having 0.6 employees per reported executive. Assessment of Remedent's management performance can provide insight into the firm performance.
| Guy Vreese Chairman Chairman, CEO, CEO of Remedent NV and President of Remedent NV |
Remedent |
Remedent Management Team Effectiveness
Remedent's management efficiency ratios could be used to measure how well Remedent manages its routine affairs as well as how well it operates its assets and liabilities.Remedent Workforce Comparison
Remedent is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 771. Remedent adds roughly 3.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.33 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17. Remedent Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Remedent Price Series Summation is a cross summation of Remedent price series and its benchmark/peer.
Remedent Notable Stakeholders
A Remedent stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Remedent often face trade-offs trying to please all of them. Remedent's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Remedent's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Guy Vreese | Chairman, CEO, CEO of Remedent NV and President of Remedent NV | Profile | |
| Philippe Acker | CFO, Chief Accounting Officer, Controller and Director | Profile | |
| Stacey Ammons | Ex Office | Profile | |
| Scott Juhl | Ex Office | Profile | |
| Mark Sernatinger | Ex Office | Profile |
About Remedent Management Performance
The success or failure of an entity such as Remedent often depends on how effective the management is. Remedent management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Remedent management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Remedent management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. The company was founded in 1986 and is headquartered in Ghent, Belgium. Remedent operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 3 people.
Remedent Workforce Analysis
Traditionally, organizations such as Remedent use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Remedent within its industry.Remedent Manpower Efficiency
Return on Remedent Manpower
| Revenue Per Employee | 134K | |
| Revenue Per Executive | 80.4K | |
| Net Income Per Employee | 44K | |
| Net Income Per Executive | 26.4K |
Complementary Tools for Remedent Pink Sheet analysis
When running Remedent's price analysis, check to measure Remedent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Remedent is operating at the current time. Most of Remedent's value examination focuses on studying past and present price action to predict the probability of Remedent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Remedent's price. Additionally, you may evaluate how the addition of Remedent to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |